Research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of NYSE AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47. The business’s 50-day simple moving average is $0.02 and its 200-day simple moving average is $0.01. The firm has a market cap of $567.50, a price-to-earnings ratio of 0.00 and a beta of 3.71.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- Bloom Energy: Powering the Future With Decentralized Energy
- What is the Shanghai Stock Exchange Composite Index?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Transportation Stocks Investing
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
